• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载外泌体的促噬泡沫型血管支架,具有 Lp-PLA2 触发释放功能,用于预防支架内再狭窄。

Exosome-Loaded Pro-efferocytic Vascular Stent with Lp-PLA-Triggered Release for Preventing In-Stent Restenosis.

机构信息

Key Laboratory for Advanced Technologies of Materials, Ministry of Education, School of Material Science and Engineering, Southwest Jiaotong University, Chengdu 610031, P.R. China.

出版信息

ACS Nano. 2022 Sep 27;16(9):14925-14941. doi: 10.1021/acsnano.2c05847. Epub 2022 Sep 6.

DOI:10.1021/acsnano.2c05847
PMID:36066255
Abstract

The efferocytosis defect is regarded as a pivotal event of atherosclerosis. The failure to clear apoptotic cells in atherosclerotic plaques under vascular stents causes a failure to resolve the inflammation underneath. However, efferocytosis repair is still confined to nonstenting therapeutics. Here, we identified a pro-efferocytotic agent and accordingly developed a bioresponsive pro-efferocytotic vascular stent aimed for poststenting healing. Exosomes derived from mesenchymal stem cells were found to be able to regulate efferocytosis SLC2a1, STAT3/RAC1, and CD300a pathways and modulate foam cell formation processes through a CD36-mediated pathway. Pro-efferocytotic exosomes were encapsulated into liposome-based multivesicular chambers and grafted onto vascular stents. The multivesicular vesicles were able to release exosomes under the Lp-PLA environment. Compared to bare metal stents, exosome-stents in the presence of Lp-PLA enhanced the ratio of apoptotic cell clearance and reduced the neointimal thickness in the mal-efferocytotic rat model. Overall, we identified a pro-efferocytic agent─exosomes that are able to regulate target cells multiple signaling pathways and are good candidates to serve complex pathological environments, and this bioresponsive pro-efferocytotic vascular stent is an attractive approach for prevention of poststenting complications.

摘要

噬作用缺陷被认为是动脉粥样硬化的关键事件。血管支架下斑块中凋亡细胞的清除失败导致炎症在支架下无法消退。然而,噬作用的修复仍然局限于非支架治疗。在这里,我们鉴定了一种促噬作用的药物,并据此开发了一种生物响应性的促噬作用血管支架,用于支架后愈合。间充质干细胞衍生的外体被发现能够调节噬作用 SLC2a1、STAT3/RAC1 和 CD300a 途径,并通过 CD36 介导的途径调节泡沫细胞形成过程。促噬作用的外体被包裹在基于脂质体的多泡室中,并嫁接到血管支架上。多泡囊在 Lp-PLA 环境下能够释放外体。与裸金属支架相比,存在 Lp-PLA 的外体支架增强了凋亡细胞清除率的比值,并减少了易噬作用大鼠模型中的新生内膜厚度。总的来说,我们鉴定了一种促噬作用的药物——外体,它能够调节靶细胞的多种信号通路,是用于复杂病理环境的良好候选药物,这种生物响应性的促噬作用血管支架是预防支架后并发症的一种有吸引力的方法。

相似文献

1
Exosome-Loaded Pro-efferocytic Vascular Stent with Lp-PLA-Triggered Release for Preventing In-Stent Restenosis.载外泌体的促噬泡沫型血管支架,具有 Lp-PLA2 触发释放功能,用于预防支架内再狭窄。
ACS Nano. 2022 Sep 27;16(9):14925-14941. doi: 10.1021/acsnano.2c05847. Epub 2022 Sep 6.
2
Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement.基线升高的脂蛋白相关磷脂酶 A2 与支架置入后再狭窄的风险增加相关。
Lipids Health Dis. 2014 Mar 1;13:41. doi: 10.1186/1476-511X-13-41.
3
Exosome-eluting stents for vascular healing after ischaemic injury.载有外泌体的支架促进缺血性损伤后血管愈合。
Nat Biomed Eng. 2021 Oct;5(10):1174-1188. doi: 10.1038/s41551-021-00705-0. Epub 2021 Apr 5.
4
Relationship between Lp-PLA2 and in-stent restenosis after coronary stenting: a 3-year follow-up study.脂蛋白相关磷脂酶 A2 与冠状动脉支架置入术后支架内再狭窄的关系:一项 3 年随访研究。
Scott Med J. 2021 Nov;66(4):178-185. doi: 10.1177/00369330211034809. Epub 2021 Jul 28.
5
Constructing Mal-Efferocytic Macrophage Model and Its Atherosclerotic Spheroids and Rat Model for Therapeutic Evaluation.构建促炎巨噬细胞模型及其动脉粥样硬化球体和治疗评价大鼠模型。
Adv Biol (Weinh). 2023 Jun;7(6):e2200277. doi: 10.1002/adbi.202200277. Epub 2023 Jan 31.
6
[Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].脂蛋白磷脂酶A2测定有助于预测动脉粥样硬化和心脑血管疾病吗?
Acta Med Croatica. 2010 Oct;64(4):237-45.
7
M2 macrophage-derived exosomes promote the c-KIT phenotype of vascular smooth muscle cells during vascular tissue repair after intravascular stent implantation.M2 巨噬细胞衍生的外泌体在血管内支架植入后血管组织修复期间促进血管平滑肌细胞的 c-KIT 表型。
Theranostics. 2020 Aug 29;10(23):10712-10728. doi: 10.7150/thno.46143. eCollection 2020.
8
Low basal levels of circulating adiponectin in patients undergoing coronary stenting predict in-stent restenosis, independently of basal levels of inflammatory markers: lipoprotein associated phospholipase A2, and myeloperoxidase.接受冠状动脉支架置入术的患者循环脂联素基础水平较低可预测支架内再狭窄,且独立于炎症标志物——脂蛋白相关磷脂酶A2和髓过氧化物酶的基础水平。
Clin Biochem. 2008 Dec;41(18):1429-33. doi: 10.1016/j.clinbiochem.2008.09.109. Epub 2008 Oct 7.
9
Preventing in-stent restenosis using lipoprotein (a), lipid and cholesterol adsorbent materials.使用脂蛋白(a)、脂质和胆固醇吸附材料预防支架内再狭窄。
Med Hypotheses. 2015 Dec;85(6):986-8. doi: 10.1016/j.mehy.2015.08.023. Epub 2015 Sep 5.
10
Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model.载有诱导型 VEGF/HGF 分泌 UCB-MSCs 的冠状动脉支架可减少猪模型中的再狭窄并增加再内皮化。
Exp Mol Med. 2018 Sep 3;50(9):1-14. doi: 10.1038/s12276-018-0143-9.

引用本文的文献

1
Efferocytosis in tissue engineering: A comprehensive review of emerging therapeutic strategies for enhanced tissue repair and regeneration.组织工程中的胞葬作用:增强组织修复与再生的新兴治疗策略综述
Bioact Mater. 2025 Jun 9;52:155-181. doi: 10.1016/j.bioactmat.2025.05.026. eCollection 2025 Oct.
2
The role of exosomal lncRNAs in cardiovascular disease: Emerging insights based on molecular mechanisms and therapeutic target level.外泌体长链非编码RNA在心血管疾病中的作用:基于分子机制和治疗靶点层面的新见解
Noncoding RNA Res. 2024 Oct 10;10:198-205. doi: 10.1016/j.ncrna.2024.10.001. eCollection 2025 Feb.
3
Efferocytosis and inflammation: a bibliometric and systematic analysis.
噬菌作用与炎症:文献计量学与系统分析
Front Med (Lausanne). 2025 Feb 10;12:1498503. doi: 10.3389/fmed.2025.1498503. eCollection 2025.
4
A cryo-shocked M2 macrophages based treatment strategy promoting repair of spinal cord injury via immunomodulation and axonal regeneration effects.一种基于冷冻休克M2巨噬细胞的治疗策略,通过免疫调节和轴突再生作用促进脊髓损伤修复。
J Nanobiotechnology. 2025 Jan 6;23(1):8. doi: 10.1186/s12951-024-03018-x.
5
Recent advances in surface functionalization of cardiovascular stents.心血管支架表面功能化的最新进展。
Bioact Mater. 2024 Oct 28;44:389-410. doi: 10.1016/j.bioactmat.2024.10.025. eCollection 2025 Feb.
6
Preparation of Time-Sequential Functionalized ZnS-ZnO Film for Modulation of Interfacial Behavior of Metals in Biological Service Environments.用于调节生物服役环境中金属界面行为的时序功能化 ZnS-ZnO 薄膜的制备。
Biomolecules. 2024 Aug 22;14(8):1041. doi: 10.3390/biom14081041.
7
Yin-Yang: two sides of extracellular vesicles in inflammatory diseases.阴阳:细胞外囊泡在炎症性疾病中的两面性。
J Nanobiotechnology. 2024 Aug 27;22(1):514. doi: 10.1186/s12951-024-02779-9.
8
Therapeutic biomaterials with liver X receptor agonists based on the horizon of material biology to regulate atherosclerotic plaque regression for devices surface engineering.基于材料生物学前沿的含肝脏X受体激动剂的治疗性生物材料,用于调节动脉粥样硬化斑块消退以进行器械表面工程。
Regen Biomater. 2024 Aug 6;11:rbae089. doi: 10.1093/rb/rbae089. eCollection 2024.
9
CircTMEM165 facilitates endothelial repair by modulating mitochondrial fission via miR-192/SCP2 and .环状跨膜蛋白165通过微小RNA-192/固醇载体蛋白2调节线粒体分裂促进内皮修复。
iScience. 2024 Mar 16;27(4):109502. doi: 10.1016/j.isci.2024.109502. eCollection 2024 Apr 19.
10
Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment.靶向递送间充质干细胞衍生的仿生外体模拟纳米囊泡与血小板膜融合治疗动脉粥样硬化。
Int J Nanomedicine. 2024 Mar 13;19:2553-2571. doi: 10.2147/IJN.S452824. eCollection 2024.